These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25497698)

  • 21. Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency.
    Tanimura K; Ebina Y; Sonoyama A; Morita H; Miyata S; Yamada H
    J Obstet Gynaecol Res; 2012 Apr; 38(4):749-52. PubMed ID: 22380425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment with lepirudin in heparin-induced thrombocytopenia. A case report].
    Nippert M; de Maistre E; Rodermann M; Vançon AC; Amrein D; Brembilla-Perrot B; Lecompte T; Zannad F; Aliot E
    Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1234-8. PubMed ID: 12611047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Argatroban for treatment of heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 2001 Feb; 43(1097):11-2. PubMed ID: 11177224
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805).
    Matsuo T; Kario K; Kodama K; Okamoto S
    Semin Thromb Hemost; 1992; 18(2):155-60. PubMed ID: 1631564
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
    Matthai WH; Hursting MJ; Lewis BE; Kelton JG
    Thromb Res; 2005; 116(2):121-6. PubMed ID: 15907526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.
    Matthai WH
    Curr Hematol Rep; 2006 Mar; 5(1):95-9. PubMed ID: 16537053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two cases of heparin-induced thrombocytopenia (HIT) and a review of the literature].
    Kaneko M; Shikata H; Kohno H; Muraoka M
    Rinsho Ketsueki; 2006 Aug; 47(8):758-63. PubMed ID: 16986715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.
    Webb DP; Warhoover MT; Eagle SS; Greelish JP; Zhao DX; Byrne JG
    J Extra Corpor Technol; 2008 Jun; 40(2):130-4. PubMed ID: 18705550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Hursting MJ
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving management strategies for heparin-induced thrombocytopenia.
    Rice L
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S15-21. PubMed ID: 16105554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
    Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST
    Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct antithrombin agents ameliorate disseminated intravascular coagulation in suspected heparin-induced thrombocytopenia thrombosis syndrome.
    Mukundan S; Zeigler ZR
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):287-9. PubMed ID: 12361208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective anticoagulation by argatroban during coronary stent implantation in a patient with heparin-induced thrombocytopenia.
    Suzuki S; Sakamoto S; Koide M; Matsuo M; Fujii K; Matsuo T
    Thromb Res; 1997 Dec; 88(6):499-502. PubMed ID: 9610961
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.
    Zayac EA; Pivalizza EG; Levine RL
    Anesth Analg; 2008 Jan; 106(1):351-2. PubMed ID: 18165611
    [No Abstract]   [Full Text] [Related]  

  • 36. Argatroban therapy in women with heparin-induced thrombocytopenia.
    Jang IK; Baron SJ; Hursting MJ; Anglade E
    J Womens Health (Larchmt); 2007; 16(6):895-901. PubMed ID: 17678460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic end point for assessing argatroban therapy for heparin-induced thrombocytopenia: learning from secondary analyses of prospective studies.
    Warkentin TW
    Chest; 2006 Jun; 129(6):1396-8. PubMed ID: 16778250
    [No Abstract]   [Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia and thrombosis in a patient with polycythemia vera.
    Hayashi T; Suyama Y; Kaneko M; Okamura J; Nakao Y; Nonaka Y; Nomura T
    Intern Med; 2004 Jul; 43(7):587-9. PubMed ID: 15335186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-induced thrombocytopenia: a critical risk/benefit analysis of patients in intensive care treated with R-hirudin.
    Schenk JF; Berg G; Mörsdorf S; Stefan B; Kroll H; Krischek B; Pindur G; Schieffer H; Wenzel E
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):151-6. PubMed ID: 10898275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intraoperative management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
    Ohno H; Yokoi M
    Masui; 2002 Jan; 51(1):30-3. PubMed ID: 11840659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.